5-HT2A and 5-HT2C receptors and their atypical regulation properties

Life Sciences

Volumn 72, Issue 22, 2003, Pages 2429-2449

  Van Oekelen, Dirk ^a   Luyten, Walter H M L ^a   Leysen, Josée E ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

5 HT2A 2C receptors; Agonists; Antagonists; Antidepressants; Antipsychotics; Regulation

Indexed keywords

2 CHLORO 11 (3 DIMETHYLAMINOPROPYLIDENE)MORPHANTHRIDINE; 2,3,3A,12B TETRAHYDRO 3 METHYL 1H DIBENZO[B,F]OXEPINO[10,11 C]PYRROLE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; CLORGYLINE; CYPROHEPTADINE; DESIPRAMINE; DOSULEPIN; EPLIVANSERIN; FLUOXETINE; IMIPRAMINE; IPRINDOLE; KETANSERIN; MAPROTILINE; METERGOLINE; METHYSERGIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PARGYLINE; PAROXETINE; PHENELZINE; RITANSERIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A AGONIST; SEROTONIN 2C AGONIST; SERTRALINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZIMELDINE; GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

AGONIST; DESENSITIZATION; DRUG MECHANISM; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; RECEPTOR DOWN REGULATION; SHORT SURVEY; ANIMAL; DRUG EFFECT; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; GTP-BINDING PROTEINS; HUMANS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0037453204     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00141-3     Document Type: Short Survey

References (163)

1. 2 receptor stimulation. Molecular Pharmacology. 43:1993;349-355.
2. 2C receptors. Journal of Neurochemistry. 64:1995;2473-2479.
3. 2 receptors in rat cerebral cortex. Journal of Neurochemistry. 46:1996;191-197.
4. 2A receptor mRNA levels and binding sites in rat frontal cortex by the agonist DOI and the antagonist mianserin. Neuropharmacology. 39(11):2000;1996-2005.
5. Anji A., Sullivan Hanley N.R., Kumari M., Hensler J.G. The role of protein kinase C in the regulation of serotonin-2A receptor expression. Journal of Neurochemistry. 77(2):2001;589-597.
6. 2C receptor PDZ recognition motif prevents receptor phosphorylation and delays resensitization of receptor responses. Journal of Biological Chemistry. 275(31):2000;23620-23626.
7. Bakish D., Cavazzoni P., Chudzik J., Ravindran A., Hrdina P.D. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biological Psychiatry. 41:1997;184-190.
8. Banerjee S.P., Kung L.S., Riggi S.J., Chanda S.K. Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature. 268(5619):1977;455-456.
9. Barak L.S., Tiberi M., Freedman N.J., Kwatra M.M., Lefkowitz R.J., Caron M.G. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. Journal of Biological Chemistry. 269:1994;2790-2795.
10. Barbaccia M.L., Brunello N., Chuang D.M., Costa E. On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of beta-adrenergic receptors. Neuropharmacology. 22:1983;373-383.
11. 1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane. Molecular Pharmacology. 44:1993;725-730.
12. Beaumont V., Hepworth M.B., Luty J.S., Kelly E., Henderson G. Somatostatin receptor desensitisation in NG108-15 cells. Journal of Biological Chemistry. 273:1998;33174-33183.
13. Bel N., Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse. 15(3):1993;243-245.
14. 5 dopamine receptors in the primate brain. Journal of Neurosciences. 15:1995;782-7836.
15. 2A receptor occurs via the endosome pathway in vitro. Molecular Pharmacology. 50:1996;306-313.
16. Bergstrom D.A., Kellar K.J. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. Journal of Pharmacology and Experimental Therapeutics. 209(2):1979;256-261.
17. 2A receptors during endocytosis. Journal of Biological Chemistry. 276:2001;8269-8277.
18. Blackshear M.A., Sanders-Bush E. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. Journal of Pharmacology and Experimental Therapeutics. 221:1982;303-308.
19. Blackshear M., Friedman R., Sanders-Bush E. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 324:1983;125-129.
20. 2 binding site after chronic administration of agonists and antagonists. Neuropharmacology. 25:1986;1267-1271.
21. 1C receptors. Naunyn Schmiedebergs Archives of Pharmacology. 348(3):1993;221-224.
22. 2C receptors expressed in the human neuroblastoma cell line SH-SY5Y. Britisch Journal of Pharmacology. 125:1998;727-734.
23. 2C receptors. Molecular Brain Research. 48(1):1997;45-52.
24. 2 receptor binding in rat brain. European Journal of Pharmacology. 109:1985;421-425.
25. 2 receptors. Life Sciences. 42:1988;2439-2445.
26. 2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience. 73:1996;531-540.
27. 2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Research. 638:1994;311-324.
28. Butler P.D., Edwards E., Barkai A.I. Imipramine and tetrabenazine: Effects on monoamine receptor binding sites and phosphoinositide hydrolysis. European Journal of Pharmacology. 160:1989;93-100.
29. 2 receptor mRNA in rat frontal cortex. Journal of Neurochemistry. 61:1993;1270-1276.
30. 2 receptor function in the brain of the guinea pig. Neuropharpmacology. 32:1993;249-256.
31. Carlsson A., Hansson L.O., Waters N., Carlsson M.L. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Life Sciences. 61:1997;75-94.
32. Chaouloff F., Baudrie V., Coupry I. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation. European Journal of Pharmacology. 249(1):1993;117-120.
33. 2A receptors. European Journal of Pharmacology. 334(1):1997;25-29.
34. 2) receptor binding sites in cerebellar granule neurons: involvement of calcium influx and a calmodulin-dependent pathway. Journal of Pharmacology and Experimental Therapeutics. 275:1995;674-680.
35. 2 receptor down-regulation by amitriptyline. Neuropharmacology. 21:1982;725-727.
36. Creese I., Sibley D.R. Receptor adaptations to centrally acting drugs. Annual Review of Pharmacology and Toxicology. 21:1981;357-391.
37. 2 receptor binding during combined administration of tricyclic antidepressant drugs and alpha 2 antagonists. Neuropharmacology. 22:1983;1203-1209.
38. Crews F.T., Smith C.B. Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment. Science. 202(4365):1978;322-324.
39. 1 receptor binding in cortex of rat after chronic administration of dothiepin. Application of the Woolf plot to analysis of binding parameters. Neuropharmacology. 24:1985;275-278.
40. Eison A.S., Eison M.S., Yocca F.D., Gianutsos G. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation. Life Sciences. 44(19):1989;1419-1427.
41. 2-mediated behavior in the rat following noradrenergic or serotonergic denervation. Journal of Neural Transmission (Gen. Sect.). 84:1991;19-32.
42. Ferguson S.S., Barak L.S., Zhang J., Caron M.G. G-protein-coupled receptor regulation; Role of G-protein-coupled receptor kinases and arrestins. Canadian Journal of Physiology and Pharmacology. 74:1996;1095-1110.
43. Ferguson S.S., Downey W.E. III, Colapietro A.M., Barak L.S., Menard L., Caron M.G. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science. 271:1996;363-366.
44. 2), alpha 2-adrenergic. imipramine and dopaminergic receptors in brain. Neuropharmacology. 22:1983;1257-1267.
45. 2 receptors in P11 cells. Molecular Pharmacology. 43:1993;726-733.
46. 2C receptor levels in the rat. Britisch Journal of Pharmacology. 123:1998;1707-1715.
47. Fuller R.W. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sciences. 55:1994;163-167.
48. Gaddum J.H., Picavelli Z.P. Two kinds of tryptamine receptors. Britisch Journal of Pharmacology. 12:1957;323-328.
49. Garland A.M., Grady E.F., Payan D.G., Vigna S.R., Bunnett N.W. Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells. Biochemical Journal. 303(Pt 1):1994;177-186.
50. Gandolfi O., Barbaccia M.L., Costa E. Comparison of iprindole.imipramine and mianserin action on brain serotonergic and beta adrenergic receptors. Journal of Pharmacology and Experimental Therapeutics. 229:1984;782-786.
51. 2A receptor: The third intracellular loop is alpha-helical and binds purified arrestins. Journal of Neurochemistry. 72:1999;2206-2214.
52. 2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. Journal of Neurochemistry. 62:1994;2262-2268.
53. 2 binding sites in rat cortex. Journal of Neural Transmission. 41(suppl.):1994;127-134.
54. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Britisch Journal of Pharmacology. 83(1):1984;235-242.
55. Gozlan H., Laporte A.M., Thibault S., Schechter L.E., Bolanos F., Hamon M. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Neuropharmacology. 33(3-4):1994;423-431.
56. 2A receptors by agonists and antagonists. Brain Research Bulletins. 56(5):2001;441-451.
57. 2A receptor desensitisation and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in HEK-293 cells. Molecular Pharmacology. 60:2001;1020-1030.
58. 2A receptors in heterologous expression systems. Journal of Neurochemistry. 63:1994;1255-1260.
59. 2 binding sites in the cerebral cortex. Journal of Neural Transmission. 59:1984;9-23.
60. Hausdorff W.P., Pitcher J.A., Luttrell D.K., Linder M.E., Kurose H., Parsons S.J., Caron M.G., Lefkowitz R.J. Tyrosine phosphorylation of G protein alpha subunits by pp60c-src. Proceedings of the National Acadamie of Sciences U S A. 89(13):1992;5720-5724.
61. Helmeste D.M., Tang S.W. Unusual acute effects of antidepressants and neuroleptics on S2-serotonergic receptors. Life Sciences. 33:1983;2527-2533.
62. Hietala J., Koulu M., Kuoppamäki M., Lappalainen J., Syvälahti E. Chronic clozapine treatment down-regulates serotonin 5-HT-1C receptors in rat brain. Progress in Neuropsychopharmacology and Biological Psychiatry. 16:1992;727-732.
63. Hjorth S., Auerbach S.B. Lack of 5-HT1A autoreceptor desensitisation following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology. 33(3-4):1994;331-334.
64. 2 receptors in rat brain: an autoradiographic study. Synapse. 14:1993;324-331.
65. Hulihan-Giblin B.A., Park Y.D., Aulakh C.S. Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain. European Journal of Pharmacology. 263(1-2):1994;213-216.
66. Hyttel J., Overo K.F., Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology (Berl). 83(1):1984;20-27.
67. Invernizzi R., Bramante M., Samanin R. Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors. European Journal of Pharmacology. 260(2-3):1994;243-246.
68. 2 receptors in P11 cells. Journal of Pharmacology and Experimental Therapeutics. 259:1991;423-429.
69. Jakab R., Goldman-Rakic P. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proceedings of the National Acadamie of Sciences U S A. 95:1998;735-740.
70. 2 receptors in human platelets via a mechanism involving protein kinase C. Journal of Pharmacology and Experimental Therapeutics. 255:1990;305-311.
71. 2 receptor-stimulated intracellular calcium mobilization in C6BU-1 glioma cells via a mechanism involving a calmodulin pathway. Journal of Neurochemistry. 61:1993;1050-1056.
72. 2 receptors in rat brain. European Journal of Pharmacology. 69:1981;515-518.
73. Kendall D.A., Nahorski S.R. 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. Journal of Pharmacology and Experimental Therapeutics. 233(2):1985;473-479.
74. Kendall D.A., Stancel G.M., Enna S.J. The inf1uence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. Journal of Neurosciences. 2:1982;354-360.
75. 2 receptors in the rat brain. Journal of Psychiatry and Neurosciences. 19:1994;63-67.
76. Koshikawa N., Durcan M.J., Dunn G., Campbell I.C. Circadian studies of 5HT2 receptors: effects of clorgyline administration. Pharmacology Biochemistry and Behavior. 30(2):1988;347-350.
77. 2 receptors. European Journal of Pharmacology. 164:1989;595-598.
78. 2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist]. Yakubutsu Seishin Kodo. 9:1989;289-292.
79. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology. 13:1995;139-150.
80. Kuoppamaki M., Seppala T., Syvalahti E., Hietala J. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol. Journal of Pharmacology and Experimental Therapeutics. 264(3):1993;1262-1267.
81. 2C receptors in the rat choroid plexus after acute clozapine treatment. European Journal of Pharmacology. 26:1994;201-208.
82. Krupnick J.G., Goodman O.B., Keen J.H., Benovic J.L. Arrestin/clathrin interaction: localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. Journal of Biological and Chemistry. 274:1997;15011-15016.
83. 2C receptors in the rat choroid plexus. Neuropsychopharmacology. 15:1996;143-151.
84. Labrecque J., Fargin A., Bouvier M., Chidiac P., Dennis M. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells. Molecular Pharmacology. 48:1995;150-159.
85. Laporte S.A., Oakley R.H., Zhang J., Holt J.A., Ferguson S.S., Caron M.G., Barak L.S. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proceedings of the National Acadamie of Sciences U S A. 96:1999;3712-3717.
86. Lee T., Tang S.W. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain. Psychiatry Research. 12(4):1984;277-285.
87. Lefkowitz R.J., Hausdorff W.P., Caron M.G. Role of phosphorylation in desensitisation of the β-adrenoreceptor. TIPS. 11:1990;190-194.
88. Leysen J.E., Janssen P.F.M., Niemegeers C.J.E. Rapid desensitisation and down-regulation of 5-HT2 receptors by DOM treatment. European Journal of Pharmacology. 163:1989;145-149.
89. Leysen J.E., Niemegeers C., Tollenaere J., Laduron P. Serotonergic component of neuroleptic receptors. Nature. 272:1978;168-171.
90. 2 receptors, roles and regulation. Annals of the New York Academy of Sciences. 600:1990;183.
91. Leysen J.E., Van Gompel P., Gommeren W., Laduron P.M. Differential regulation of dopamine-D2 and serotonin-S2 receptors by chronic treatment with the serotonin-S2 antagonists, ritanserin, and setoperone. Dahl S.G.et al. Clinical pharmacology in Psychiatry. 1987;214-224 Springer Verlag, Berlin, Heidelberg.
92. Leysen J.E., Van Gompel P., Gommeren W., Woestenborghs R., Janssen P. Down-regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists ritanserin and setoperone. Psychopharmacology. 88:1986;434-444.
93. Leysen J.E., Van Gompel P., Verwimp M., Niemegeers C.J. Role and localization of serotonin2 (S2)-receptor-binding sites: effects of neuronal lesions. Advances in Biochemistry and Psychopharmacology. 37:1983;373-383.
94. 11-proteins. Brain Research. 775(1-2):1997;225-228.
95. 2A receptor antagonist. Journal of Pharmacology and Experimental Therapeutics. 260(1):1992;146-159.
96. 2A receptor-mediated excitatory effects of serotonin on interneurons in rat piriform cortex. Synapse. 21(2):1995;123-130.
97. 2 receptor density in rat cerebral cortex. Life Sciences. 45:1989;1397-1406.
98. 2 receptors following chronic administration of imipramine. Neurophamacology. 23:1984;1265-1269.
99. 2 receptors in rat brain. Neuropsychopharmacology. 2:1989;81-87.
100. Menard L., Ferguson S.S., Zhang J., Lin F.T., Lefkowitz R.J., Caron M.G., Barak L.S. Synergistic regulation of beta2-adrenergic receptor sequestration: Intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization. Molecular Pharmacology. 51:1997;800-808.
101. 2 receptor number. European Journal of Pharmacology. 126:1986;159-162.
102. Mikuni M., Meltzer H.Y. Reduction of serotonin-2 y receptors in rat cerebral cortex after subchronic administration of imipramine, chlorpromazine, and the combination thereof. Life Sciences. 34:1984;87-92.
103. 2 receptor immunoreactivity on cholinergic neurons of the pontomesencephalic tegmentum shown by double immunofluorescence. Brain Research. 627(1):1993;49-54.
104. 2 receptors in the rat brain. Neuroscience. 54:1993;701-717.
105. Navarro A., Zapata R., Canela E.I., Mallol J., Luis C., Franco R. Epidermal growth factor (EGF)-induced up-regulation and agonist- and antagonist-induced desensitisation and internalization of A1 adenosine receptors in a pituitary-derived cel1 line. Brain Research. 816:1999;47-57.
106. 2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y. Journal of Neurochemistry. 69:1997;1031-1038.
107. Ohno Y., Ishibashi T., Okada K., Ishida K., Nakamura M. Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 19:1995;1091-1101.
108. Ong W.Y., Tan K.K., Garey L.J. Differential localisation of the metabotropic glutamate receptor mGluR1a and the ionotropic glutamate receptor GluR2/3 in neurons of the human cerebral cortex. Exp. Brain Res. 119:1998;367-374.
109. Orsini M.J., Benovic J.L. Characterization of dominant negative arrestins that inhibit beta2-adrenergic receptor internalization by distinct mechanisms. Journal of Biological Chemistry. 273:1998;34616-34622.
110. 2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells. Life Sciences. 47:1990;2009-2019.
111. Pauwels P.J., Van Gompel P., de Chaffoy de Courcelles D., Leysen J.E. Agonist-induced desensitisation of 5-HT2 receptors on cultured calf aortic smooth muscle cells. Neurochemistry International. 12:1988;409-414.
112. Pazos A., Hoyer D., Palacios J.M. The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. European Journal of Pharmacology. 106:1984;539-546.
113. Pehek E.A. Local infusion of the seotonin antagonist ritanserin or ICS205930 increases in vivo dopamine release in the rat medial frontal cortex. Synapse. 24:1996;12-19.
114. Peroutka S.J., Lebovitz R.M., Snyder S.H. Two distinct central serotonin receptors with different physiological functions. Science. 212:1981;827-829.
115. Peroutka S.J., Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 210:1980;88-90.
116. 2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. Journal of Pharmacology and Experimental Therapeutics. 215:1980;582-587.
117. Pfeiffer R., Kirsch J., Fahrenholz F. Agonist and antagonist-dependent interna1ization of the human vasopressin V2 receptor. Experimental Cell Research. 244:1998;327-339.
118. Pippig S., Andexinger S., Lohse M.J. Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Molecular Pharmacology. 47(4):1995;666-676.
119. 2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist. Biochemical Pharmacology. 42:1991;1099-1105.
120. 1C/2 receptor agonists and antagonists. European Journal of Pharmacology. 244:1993;1-5.
121. 1C receptors by serotonergic drugs in the rat. Genetic Pharmacology. 25:1994;1279-1284.
122. Premont R.T., Inglese J., Lefkowitz R.J. Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9:1995;175-182.
123. 2A receptors in rat brain. Canadian Journal of Physiology and Pharmacology. 73:1995;1686-1691.
124. 2A signal transduction in senescent rats: Reversal following inhibition of protein kinase C. Neuroscience. 66:1995;891-901.
125. Rahman S., Neuman R.S. Multiple mechanisms of serotonin 5-HT2 receptor desensitisation. European Journal of Pharmacology. 238(2-3):1993;173-180.
126. 2 receptors. European Journal of Pharmacology. 89:1983;325-326.
127. 2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain. Molecular Pharmacology. 43(1):1993;84-89.
128. 2 receptor antagonist. European Journal of Pharmacology. 246(1):1993;73-80.
129. 2 receptor antagonist. Journal of Biological Chemistry. 269(1):1994;396-401.
130. Roettger B.F., Ghanekar D., Rao R., Toledo C., Yingling J., Pinon D., Miller L.J. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Molecular Pharmacology. 51:1997;357-362.
131. 2 receptor mRNA levels. European Journal of Pharmacology. 207:1991;169-172.
132. Roth B.L., Hamblin M., Ciaranello R.D. Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms. Neuropsychopharmacology. 3(5-6):1990;427-433.
133. 2A receptor desensitisation can occur without down-regulation. Journal of Pharmacology and Experimental Therapeutics. 275:1995;1638-1646.
134. Rutter J.J., Gundlah C., Auerbach S.B. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neuroscience Letters. 171(1-2):1994;183-186.
135. Sanders-Bush E., Breeding M., Knoth K., Tsutsumi M. Sertraline-induced desensitisation of the serotonin 5HT-2 receptor transmembrane signalling system. Psychopharmacology. 99:1989;64-69.
136. Sanders-Bush E., Breeding M., Roznoski M. 5HT2 binding sites after mianserin: comparison of loss of sites and brain levels of drug. European Journal of Pharmacology. 133(2):1987;199-204.
137. Saucier C., Morris S.J., Albert P.R. Endogenous serotonin-2A and-3C receptors in balb/c-3T3 cells revealed in serotonin-free medium. Biochemical Pharmacology. 56:1998;1347-1357.
138. Saucier C., AIbert P.R. Identification of an endogenous 5-hydroxytryptamine2A receptor in NIH-3T3 cells: agonist-induced downregulation involves decreases in receptor RNA and number. Journal of Neurochemistry. 68(5):1997;1998-2011.
139. Schoups A.A., De Potter W.P. Species dependence of adaptations at the pre- and postsynaptic serotonergic receptors following longterm antidepressant drug treatment. Biochemical Pharmacology. 37:1988;4451-4460.
140. 2 and beta-adrenergic receptors. Neuropharmacology. 25:1986;1301-1306.
141. Sibley D.R., Strasser R.H., Benovic J.L., Daniel K., Lefkowitz R.J. Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution. Proceedings of the National Acadamie of Sciences U S A. 83(24):1986;9408-9412.
142. 2C, receptor. Psychopharmacology (Berlin). 144(3):1999;248-254.
143. Snyder S.H., Peroutka S.J. A possible role of serotonin receptors in antidepressant drug action. Pharmacopsychiatria. 15(4):1982;131-134.
144. Stockmeier C.A., Kellar K.J. In vivo regulation of the serotonin-2
145. Stolz J.F., Marsden C.A., Middlemiss D.N. Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology. 80:1983;150-155.
146. 2 receptors following chronic treatment with amperozide. Journal of Receptor Research. 13:1993;379-392.
147. 2 antagonism. Vanhoutte P.M., Saxena P.R., Paoletti R., Brunello N. Serotonin, from biology to pharmacology and therapeutics. 1993;263-270 Kluwer, Dordrecht, The Netherlands.
148. Svensson T.H., Usdin T. Feedback inhibition of brain noradrenaline neurons by tricyclic antidepressants: alpha-receptor mediation. Science. 202(4372):1978;1089-1091.
149. Tobin A.B. Phosphorylation of phospholipase C-coupled receptors. Pharmacological Therapeutics. 75(2):1997;135-151.
150. Todd K.G., McManus D.J., Baker G.B. Chronic administration of the antidepressants phenelzine, despiramine, clomipramine, or matrotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites. Cellular and Molecular Neurobiology. 15(3):1995;361-370.
151. Toth M., Shenk T. Antagonist-mediated down-regulation of 5-hydroxytryptamine type 2 receptor gene expression: Modulation of transcription. Molecular Pharmacology. 45:1994;1095-1100.
152. Trouvin J.H., Gardier A.M., Chanut E., Pages N., Jacquot C. Life Sciences. 52(18):1993;187-192.
153. Tsao P., von Zastrow M. Downregulation of G protein-coupled receptors. Current Opinion Neurobiology. 10:2000;365-369.
154. Ulrichsen J., Partilla J.S., Dax E.M. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology (Berlin). 107(2-3):1992;229-235.
155. 2 receptors in Swiss 3T3 cells. Neuroreport. 4:1993;1327-1330.
156. 2C receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone. European Journal of Pharmacology. 425:2001;21-32.
157. 2 and thrombin receptor desensitisation. Journal of Biological Chemistry. 270:1995;4813-4821.
158. 2C receptor accompanies agonist-mediated desensitisation. Molecular Pharmacology. 48:1995;200-205.
159. 2A receptors in vitro and in vivo. Annals of the New York Academie of Sciences. 861:1998;121-127.
160. 2A receptors in vitro and in vivo. Neuro-science. 91:1999;599-606.
161. Wilmot C.A., Szczepanik A.M. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Research. 487(2):1989;288-298.
162. Yu S.S., Lefkowitz R.J., Hausdorff W.P. Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. Journal of Biological Chemistry. 268(1):1993;337-341.
163. Zhang J., Barak L.S., Winkier K.E., Caron M.G., Ferguson S.S. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. Journal of Biological Chemistry. 272:1997;27005-270014.